Search Results 911-920 of 17047 for monoclonal antibody

1. Trial to Assess Safety and Effectiveness of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) - Mayo Clinic

   ... antibody MOR202 in adult subjects with in Anti-PLA2R Antibody Positive Membranous Nephropathy (newly diagnosed/relapsed/refractory). Participation ...

2. Clinical trials - Oncology (Medical)

   This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...

3. High blood protein Causes - Mayo Clinic

   https://www.niddk.nih.gov/health-information/kidney-disease/amyloidosis. Accessed Sept. 16, 2024. Monoclonal gammopathy of undetermined significance (MGUS).

4. A Study of SC-006 in Subjects With Advanced Cancer - Mayo Clinic

   ... monoclonal antibodies, antibody drug conjugates, radioimmunoconjugates, or T-cell orother cell-based therapies: 4 weeks (2 weeks permissible before the ...

5. Ph 3 Trial of Blinatumomab vs Investigator's Choice of Chemotherapy in Patients with Relapsed or Refractory ALL - Mayo Clinic

   Blinatumomab, a bispecific monoclonal antibody construct that enables CD3-positive T cells to recognize and eliminate CD19-positive acute lymphoblastic ...

6. The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis - Mayo Clinic

   History of Grade ≥ 3 infusion-associated AEs or hypersensitivity to another monoclonal antibody, or known hypersensitivity to diphenhydramine or acetaminophen ...

7. Immune Predictors of Response to Pembrolizumab Therapy in Stage IV Melanoma Patients - Mayo Clinic

   Has had a prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior to study Day 1 or who has not recovered (i.e., ≤ Grade 1 or at baseline) from ...

8. A Study to Assess the Culture, PCR, Serology and Symptoms of COVID-19 - Mayo Clinic

   Consent waived. Topic 6 - Isolation of human peripheral blood mononuclear cells (PBMC) for development of human monoclonal antibodies, and investigation of HLA ...

9. A Study of the Safety and Effectiveness of QPI-1002 for the Prevention of Delayed Graft Function in Transplant Recipients from Older Kidney Donors who have Died - Mayo Clinic

   ... monoclonal antibodies per center standard of care. Must be up-to-date on ... Has a positive T- or B-cell flow cross-match AND donor specific anti-HLA antibody ...

10. Services - Immune Monitoring Core - Mayo Clinic Research

    Services · Mass cytometry- CyTOF using the Helios instrument. · Custom heavy metal conjugation of antibodies through collaboration with the Antibody Hybridoma ...